Effects of a non-peptide CRF antagonist (DMP696) on the behavioral and endocrine sequelae of maternal separation

Neuropsychopharmacology

Volumn 26, Issue 5, 2002, Pages 574-582

  Maciag, Carla M ^a   Dent, Gersham ^a   Gilligan, Paul ^a   He, Liqi ^a   Dowling, Krista ^a   Ko, Tracey ^a   Levine, Seymour ^b   Smith, Mark A ^a,c  

^a DUPONT COMPANY   (United States)

^b UNIVERSITY OF DELAWARE   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

ACTH; Antagonist; Corticotropin releasing factor; Maternal separation; Plus maze; Rat; Stress

Indexed keywords

8 (2,4 DICHLOROPHENYL) 4 [2 METHOXY 1 (METHOXYMETHYL)ETHYLAMINO] 2,7 DIMETHYLPYRAZOLO[1,5 A][1,3,5]TRIAZINE; CHLORDIAZEPOXIDE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; MALE; MATERNAL DEPRIVATION; MAZE TEST; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION; STRESS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; CHLORDIAZEPOXIDE; FEMALE; HANDLING (PSYCHOLOGY); MALE; MATERNAL DEPRIVATION; MAZE LEARNING; PREGNANCY; PYRAZOLES; RATS; RATS, LONG-EVANS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS, PSYCHOLOGICAL; TRIAZINES;

EID: 0036201129     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(01)00398-0     Document Type: Article

References (31)

1. Childhood abuse and neglect: Specificity of effects on adolescent and young adult depression and suicidality
2. The effects of early rearing environment on the development of GABAA and central benzodiazepine receptor levels and novelty-induced fearfulness in the rat
3. Mouse strain differences in the behavioral effects of corticotropin releasing factor (CRF) and the CRF antagonist alpha-helical CRF9-41
4. Pharmacological comparison of two corticotropin-releasing factor antagonists: In vivo and in vitro studies
5. The role of corticotropin-releasing factor-norepinephrine systems in mediating the effects of early experience on the development of behavioral and endocrine responses to stress
6. Corticotropin releasing factor (CRF) receptor modulators: Progress and opportunities for new therapeutic agents
7. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents
8. Differential behavioral and endocrinological effects of corticotropin-releasing hormone (CRH) in the Syracuse high- and low-avoidance rats
9. 4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: A potent, orally bioavailable CRF(1) receptor antagonist
10. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood
11. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action
12. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
13. 1 receptor antagonist R121919 depends on innate emotionality in rats
14. 1 receptor antagonist, CP 154,526, in the separation-induced vocalization anxiolytic test in rat pups
15. Stressful life events, genetic liability, and onset of an episode of major depression in women
16. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors
17. Long-term behavioral and neuroendocrine adaptations to adverse early experience
18. Long-term biobehavioral effects of maternal separation in the rat: Consistent or confusing?
19. Infantile experience and resistence to physiological stress
20. Influence of neonatal rearing conditions on stress-induced adrenocorticotropin responses and norepinephrine release in the hypothalamic paraventricular nucleus
21. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: Association with reduction in glucocorticoid receptor mRNA levels
22. 1 receptor antagonist
23. Postnatal handling increases hippocampal type II, glucocorticoid receptors and enhances adrenocortical negative-feedback efficacy in the rat
24. The influence of postnatal handling on adult neuroendocrine and behavioural stress reactivity
25. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients
26. Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioral and neuroendocrine consequences of adverse early life events
27. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
28. Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats
29. CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors
30. Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated